Arcutis Biotherapeutics, Inc. ARQT Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s quick ratio?
- Arcutis Biotherapeutics, Inc. (ARQT) reported quick ratio of 2.5× in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s quick ratio changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s quick ratio decreased by 27.1% year-over-year, from 3.4× to 2.5×.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s quick ratio has grown at a -25.4% compound annual growth rate (CAGR), from 13× to 3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.